ArticlePharmaceutical medicine2025

Survey on the Role of Comparative Efficacy Studies Required for Biosimilar Monoclonal Antibody Approval in Japan to Justify the Quality Attribute Differences Between Biosimilars and Their Reference Products Based on the Pharmaceuticals and Medical Devices Agency (PMDA) Assessments.

Kanoko Goto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.